| scholarly article | Q13442814 |
| P50 | author | José C Crispín | Q89149212 |
| P2093 | author name string | Jorge Alcocer-Varela | |
| Araceli Martínez | |||
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| Cytokines and systemic lupus erythematosus | Q33873329 | ||
| Regulatory T cells in autoimmmunity*. | Q33904108 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Cell interactions in the induction of tolerance: the role of thymic lymphocytes | Q34700680 | ||
| Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
| B-cell and T-cell function in systemic lupus erythematosus | Q40490331 | ||
| Induction of autoantibody production is limited in nonautoimmune mice | Q40723212 | ||
| CD4+CD25high regulatory cells in human peripheral blood | Q56905059 | ||
| Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices | Q57910636 | ||
| Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission | Q73434353 | ||
| Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population | Q73740429 | ||
| Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus | Q77143628 | ||
| T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms | Q77903156 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| lupus erythematosus | Q188297 | ||
| immunology | Q101929 | ||
| P304 | page(s) | 273-276 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Journal of Autoimmunity | Q15716783 |
| P1476 | title | Quantification of regulatory T cells in patients with systemic lupus erythematosus | |
| P478 | volume | 21 |
| Q34695479 | A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta |
| Q92126889 | A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus |
| Q36330527 | Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling |
| Q84843142 | Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance |
| Q81990288 | Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus |
| Q35223219 | An essential protective role of IL-10 in the immunological mechanism underlying resistance vs. susceptibility to lupus induction by dendritic cells and dying cells |
| Q38841726 | Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus |
| Q34285479 | Apolipoprotein A-I Modulates Regulatory T Cells in Autoimmune LDLr−/−, ApoA-I−/− Mice |
| Q82249664 | Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus |
| Q34776189 | Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis |
| Q58861262 | Auto-immunité humorale et cellulaire : de la physiologie à la pathologie |
| Q36979743 | Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity |
| Q64232439 | Autoimmune Disease-Associated Hypertension |
| Q81176004 | Autoimmunity in common variable immunodeficiency |
| Q43736626 | Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells |
| Q37253583 | CD4(+)CD25(+)CD127(-) and CD4(+)CD25(+)Foxp3(+) Regulatory T Cell Subsets in Mediating Autoimmune Reactivity in Systemic Lupus Erythematosus Patients. |
| Q36984865 | CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases |
| Q35178495 | CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game |
| Q33765809 | CD4⁺CD25⁻Foxp3⁺ T cells: a marker for lupus nephritis? |
| Q84371371 | Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome |
| Q36242848 | Cellular and molecular mechanisms of regulation of autoantibody production in lupus |
| Q35568168 | Chinese medicine bu xu hua yu recipe for the regulation of treg/th17 ratio imbalance in autoimmune hepatitis |
| Q34056359 | Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population |
| Q34897189 | Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study |
| Q34221885 | Compensatory T-cell regulation in unaffected relatives of SLE patients, and opposite IL-2/CD25-mediated effects suggested by coreferentiality modeling |
| Q36464495 | Correlation of circulating glucocorticoid-induced TNFR-related protein ligand levels with disease activity in patients with systemic lupus erythematosus |
| Q36134951 | Cutaneous manifestations of systemic lupus erythematosus. |
| Q36706485 | Cytokines and Effector/Regulatory Cells Characterization in the Physiopathology of Cutaneous Lupus Erythematous: A Cross-Sectional Study |
| Q36659210 | Cytokines in systemic lupus erythematosus |
| Q58390463 | DNA methylation as a transcriptional regulator of the immune system |
| Q42956126 | Decrease of regulatory T cells in patients with systemic lupus erythematosus |
| Q24645016 | Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura |
| Q35624565 | Deficiency of foxp3 regulatory T cells exacerbates autoimmune arthritis by altering the synovial proportions of CD4 T cells and dendritic cells |
| Q37041928 | Distinct roles of helper T-cell subsets in a systemic autoimmune disease |
| Q40263037 | Down-regulation of nectin-4 inhibits apoptosis in systemic lupus erythematous (SLE) through targeting Bcl-2/Bax pathway |
| Q87438877 | Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice |
| Q83226583 | Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis |
| Q37690038 | Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients |
| Q81277364 | Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB x NZW F mice |
| Q35638169 | Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids |
| Q54549498 | Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. |
| Q35081173 | Expansion of CD4+CD25+ helper T cells without regulatory function in smoking and COPD |
| Q36228688 | Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells |
| Q28067781 | Follicular Helper T Cells in Systemic Lupus Erythematosus: Why Should They Be Considered as Interesting Therapeutic Targets? |
| Q37804609 | FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells |
| Q36566751 | Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin |
| Q52584033 | Functional Defects of Treg Cells: New Targets in Rheumatic Diseases, Including Ankylosing Spondylitis. |
| Q24615454 | Genes, tolerance and systemic autoimmunity |
| Q35954523 | Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population |
| Q36193272 | Granulocyte colony-stimulating factor treatment ameliorates lupus nephritis through the expansion of regulatory T cells |
| Q24656069 | Human T regulatory cell therapy: take a billion or so and call me in the morning |
| Q44672907 | Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus |
| Q36395703 | Imbalance of regulatory T cells in human autoimmune diseases |
| Q34193132 | Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus |
| Q81239549 | Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15 |
| Q34974740 | Immunopathogenic mechanisms in tourette syndrome: A critical review |
| Q35099671 | Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study |
| Q36298357 | Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome |
| Q34536425 | Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension |
| Q37120570 | Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus? |
| Q44918100 | Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice |
| Q37552021 | Interleukin-17 and systemic lupus erythematosus: current concepts |
| Q54621895 | Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. |
| Q33935880 | Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells |
| Q50201499 | Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype. |
| Q45952178 | Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. |
| Q33403373 | Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants |
| Q33294845 | Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions |
| Q35867038 | Lupus nephritis: an overview of recent findings |
| Q44096997 | Mechanisms behind flare of renal lupus during murine pregnancy |
| Q34615216 | Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases |
| Q34361763 | Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus |
| Q34412837 | Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus |
| Q36189566 | Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. |
| Q36139749 | N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial |
| Q33381309 | NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis |
| Q37366061 | Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells |
| Q81342162 | Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis |
| Q41608958 | Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis |
| Q60188546 | Nouvelles approches immunopathologiques de l’hypertension artérielle pulmonaire |
| Q41140315 | PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells |
| Q38654764 | Pathological conditions re-shape physiological Tregs into pathological Tregs |
| Q37510251 | Porphyromonas gingivalis infection reduces regulatory T cells in infected atherosclerosis patients |
| Q56598969 | Potential Immune Biomarkers in Diagnosis and Clinical Management for Systemic Lupus Erythematosus |
| Q35867030 | Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction |
| Q53331987 | Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus. |
| Q44646641 | Quantitative and functional profiles of CD4+ lymphocyte subsets in systemic lupus erythematosus patients with lymphopenia |
| Q53654834 | Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. |
| Q34592421 | Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus |
| Q35858597 | Regulatory T Cell Responses to High-Dose Methylprednisolone in Active Systemic Lupus Erythematosus |
| Q35725777 | Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis |
| Q38972466 | Regulatory T Cells in SLE: Biology and Use in Treatment |
| Q37478243 | Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease |
| Q54512584 | Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus. |
| Q37338455 | Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development |
| Q36562855 | Regulatory T cells in human autoimmune diseases |
| Q37129619 | Regulatory T cells in systemic lupus erythematosus: past, present and future |
| Q43513695 | Regulatory T-cell therapy: is it ready for the clinic? |
| Q37973328 | Regulatory T-cell-associated cytokines in systemic lupus erythematosus |
| Q83163076 | Retrospective analysis on the impact of tuberculosis on patients with systemic lupus erythematosus (SLE) |
| Q38497370 | Role of regulatory T cells in rheumatoid arthritis: facts and hypothesis. |
| Q64073753 | Significant association of CD4CD25Foxp3 regulatory T cells with clinical findings in patients with systemic lupus erythematosus |
| Q82205254 | Study on the Relationship Between Th17 Cells and Unexplained Recurrent Spontaneous Abortion |
| Q53804977 | Superantigen influence in conjunction with cytokine polymorphism potentiates autoimmunity in systemic lupus erythematosus patients. |
| Q33473900 | Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells |
| Q37366068 | Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells |
| Q36969905 | Systemic lupus erythematosus: new molecular targets |
| Q90259009 | T cell-specific STAT3 deficiency abrogates lupus nephritis |
| Q35214963 | T cells as a therapeutic target in SLE. |
| Q34075552 | T cells as therapeutic targets in SLE. |
| Q38609536 | T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity |
| Q37995556 | TLR7 and TLR9 in SLE: when sensing self goes wrong |
| Q58766781 | The Proportion of Regulatory T Cells in Patients with Systemic Lupus Erythematosus: A Meta-Analysis |
| Q38725966 | The T helper type 17/regulatory T cell paradigm in pregnancy |
| Q84443643 | The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients |
| Q28292137 | The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward |
| Q54587598 | The role of CD4CD25 T cells in autoantibody production in murine lupus. |
| Q37851851 | The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension. |
| Q33769528 | The type of responder T-cell has a significant impact in a human in vitro suppression assay |
| Q24804340 | Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases |
| Q26772335 | Translating Treg Therapy in Humanized Mice |
| Q35631769 | Use of laser microdissection in the analysis of renal-infiltrating T cells in murine lupus |
Search more.